Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
0.42x
ASTRAZEN's operating cash flow was significantly below net income in FY 2025, suggesting earnings include substantial non-cash items.
Free Cash Flow
₹636.10M
ASTRAZEN's free cash flow was ₹636.10M in FY 2025, up 271.8% from FY 2024.
Dividend Coverage
1.1x
ASTRAZEN's free cash flow covered dividends 1.1x in FY 2025 but leaves limited surplus.
CapEx Intensity
2.7%
Capital expenditure was 2.7% of operating cash flow in FY 2025 for ASTRAZEN, indicating a capital-light business.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | 2.20B | 1.56B | |
| Cash flow Operating Activities | 278.70M | 653.60M | |
| Investments in PPE | -107.60M | -17.50M | |
| Cash flow Investing Activities | 217.40M | 308.00M | |
| Dividend Paid | -400.00M | -600.00M | |
| Cash flow Financing Activities | -443.80M | -655.90M | |
| Cash at beginning of period | 5.00B | 5.06B | |
| Cash at end of period | 5.06B | 5.36B | |
| Free Cash Flow | 171.10M | 636.10M |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025